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HuTSP, a serine proteinase which is specifically associated with activated T lymphocytes, was purified to homogeneity 
and characterized. N-terminal amino acid sequencing revealed identity with a sequence predicted from the human Hanu- 
kah factor (HF) gene, which was isolated from a human T cell cDNA library. The dimeric structure of HuTSP, together 
with its extensive sequence homologies with the murine T cell specific proteinase, MTSP-1, suggests phylogenetic onser- 
vation of this wine proteinase family. 
Serine proteinase; (Human T cell, Murine T cell) 
1. INTRODUCTION 
The molecular mechanisms by which T cells 
elicit their multiple effector functions is still a mat- 
ter of debate. However, with the aid of classical 
biochemistry as well as recombinant DNA 
technology, a great number of T cell derived solu- 
ble mediators such as lymphokines [1,2], 
leukolysins [3] and serine proteinases [4-71 have 
been defined which are believed to play important 
roles in various T cell mediated processes uch as 
cytolysis [8] and regulation of cellular and humoral 
immune responses [1,2,9]. We [4] and others [5-71 
have previously isolated and characterized a serine 
proteinase termed synonymously mouse T cell 
associated proteinase 1 (MTSP-1) [4], BLT- 
esterase [6], Granzyme A [5] and SE-1 [7] from 
cloned mouse CDS+ T lymphocytes (TLC). It was 
shown that this enzyme is encoded by the Hanukah 
factor (HF) gene isolated from CD8+ TLC by sub- 
traction cDNA methodology [ 10-121. Functional 
studies suggest hat MTSP-1 which is specific for 
T cells and represents the major proteolytic activity 
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in T effector cells is involved in processes uch as 
T cell mediated killing [ 131, induction of B cells [4] 
and extravasation [14,151. 
Recently, we have succeeded in isolating a 
similar serine proteinase from a human CDV T 
cell clone [16]. Here, we report that this enzyme, 
termed human T cell associated proteinase 
(HuTSP), has an amino-terminal sequence iden- 
tical with that predicted from a human CDS+ TLC 
derived cDNA clone termed human HF [ 171. 
2. MATERIALS AND METHODS 
2.1. T cells and culture medium 
The CD8+ T lymphocyte clone (TLC) UA B34.C7 was de- 
rived from the synovial fluid of patient UA with reactive ar- 
thritis after rubella infection as described [18,19]. Culture 
medium was RPM1 1640 supplemented with L-glutamine 
(2 mM), penicillin (50 U/ml), streptomycin (50 /rg/ml), 5% 
pooled AB serum and recombinant interleukin 2 (50 U/ml; 
rIL-2 kindly provided by Dr E. Liehl, Sandoz 
Forschungsinstitut, Vienna). At bi-weekly intervals cells were 
restimulated with irradiated (3000 rad) peripheral blood 
mononuclear cells in the presence of phytohemagglutinin 
(PHA, 2.5 pg/ml, Gibco). 
2.2. Assays for amidolytic and esterolytic activity 
Amidolytic activity was determined using Tos-Gly-Pro-Arg- 
p-nitroanilide (NA; Chromozym TR4, Boehringer Mannheim, 
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FRG). 100~1 of a dilution of test samples were mixed with 
100~1 of 0.1 M Tris-HCl (pH 8.9, containing 3 x 10m4 M 
substrate. Incubation was performed at 37”C, the absorbance 
of the resulting p-nitroaniline was measured after different time 
intervals at 405 nm and amidolytic activity was standardized 
defining one arbitrary unit (U) as an absorbance value of 
0.01/h. Esterolytic activity was determined by mixing 20 ~1 of 
sample dilution with 180 ~1 substrate reaction mixture [O. 1 M 
Tris-HCl (pH 8.0), 10e4 M N-a-benzyloxycarbonyl lysyl 
thiobenzyl ester (BLT) and 10m4 M dithiobis(nitrobenzoic acid)] 
and reading the absorbance at 405 nm after 30 min at room 
temperature. One BLT unit (U) was arbitrarily defined as an ab- 
sorbance value of 1.0/30 min. 
2.3. Purification of huTSP and SDS gel electrophoresis 
TLC UA B34.C7 cells were lysed by suspending cells from ex- 
ponentially growing cultures in 10 mM Tris-HCI (pH 7.9, con- 
taining 0.1% (v/v) Triton X-100 at a cell density of 5 x lO’/ml. 
After 1 h on ice, lysates were centrifuged at 3000 x g to remove 
particulate material and stored at - 70°C. HuTSP was purified 
from lysates previously adjusted to 1 mg/ml heparin on a p- 
aminobenzamidine-Sepharose column (Pharmacia, Freiburg; 
8 ml gel bed, flow rate 0.1 ml/min) equilibrated in 0.1 M Tris- 
HCl (pH 8.0), 1 mg/ml heparin (buffer A). The bulk of irrele- 
vant protein was removed from the column with a linear salt 
gradient ranging from 0 to 1 M NaCl in buffer A. Thereafter, 
elution was performed with 1 M arginine-HCl in buffer A with 
or without heparin. Fractions containing HuTSP activity were 
pooled and analysed under reducing and non-reducing condi- 
tions in 10% SDS-polyacrylamide gels (SDS-PAGE) according 
to Laemmli. Proteins were stained with silver using the method 
of Ansorge [20]. 
2.4. Affinity labeling of huTSP and analysis of labeled protein 
Purified HuTSP (without heparin) was dialysed against 
20 mM NH4HC0s (pH 8.5), lyophilized and redissolved in 
100,ul of 10 mM Tris-HCl (pH 8.0) containing 30 pCi 
[3H]diisopropyl fluorophosphate (DFP; Amersham, Braun- 
schweig). Aliquots were run on 10% Laemmli gels under reduc- 
ing and non-reducing conditions. Gels were subsequently 
soaked in a fluorographic enhancer (EN’HANCE; NEN, 
Dreieich), dried and autoradiographed on Kodak X-Omat AR 
films at -70°C for 7 days. 
2.5. Amino acid sequence analysis 
HuTSP protein (1Opg f: 200 PM) was run on SDS-PAGE 
under non-reducing conditions, electroblotted onto a silicon- 
ized glass-fiber sheet, detected by Coomassie blue staining, ex- 
cised and applied to a gas-phase sequencer (type 47OA, Applied 
Biosystems) according to Eckerskorn et al. [21]. Analysis of 
phenylthiohydantoin derivatives was performed with an 
isocratic HPLC system [22]. 
3. RESULTS AND DISCUSSION 
HuTSP was isolated from detergent lysates of 
CDS+ TLC UA B34.C7. The enzyme was purified 
to homogeneity by virtue of affinity chromatogra- 
phy on p-aminobenzamidine-Sepharose using a 
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Fig. 1. SDS-PAGE analysis of unlabeled or [‘HIDFP-labeled 
huTSP under reducing (1) and non-reducing (2) conditions. (A) 
100 ng samples of affinity-purified HuTSP were run on 10% 
SDS-polyacrylamide gels after pretreatment in the presence or 
absence of 10 mM DTT. Protein was detected by silver staining. 
(B) 100 ng huTSP were incubated in buffer containing 30,&i 
[3H]DFP for 12 h at 37°C. [‘H]DFP-binding protein was 
revealed as described in section 2. 
two-step gradient. Proteinase activity in individual 
fractions was monitored with the unspecific 
esterase substrate BLT. Enzyme activity of pooled 
fractions was determined using the model peptide 
Tos-Gly-Pro-Arg-pNA which was shown before to 
be an optimal substrate for HuTSP [16]. Table 1 
lists the results of a typical purification of HuTSP 
from 7 x lo8 cells. The proteinase was purified 
about 150-fold, yielding 57% residual activity. 
Notably, the amount of active enzyme recovered 
by this method by far exceeds that obtained with 
another purification protocol described before 
[16]. When analysed in SDS-PAGE (fig.lA), 
HuTSP migrated at a molecular mass of - 50 kDa 
under non-reducing conditions and as one band of 
-25 kDa under reducing conditions, suggesting 
that it is a disulfide-linked homodimer, a structure 
also found recently for MTSP-1 [4]. That HuTSP 
is a serine proteinase is based on its sensitivity to 
inhibitors such as PMSF and antithrombin III [ 161 
as well as its reactivity with the catalytic site 
specific ligand [3H]DFP (fig.lB). The substrate 
specificity of HuTSP as determined on a panel of 
chromogenic model peptides revealed that the en- 
zyme has an exquisite specificity for the tripeptide 
Gly-Pro-Arg [ 151, an amino acid sequence also 
recognized by human thrombin [23]. 
Alignment of the amino-terminal amino acid se- 
quence, i.e. 18 amino acids, of HuTSP to that 
predicted from HuHF cDNA recently isolated by 
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Table 1 
Summary of huTSP affinity purification from TLC UA B34.C7 
Step Protein Enzyme Specific Purification Recovery 
(mg) activity activity (-fold) WJ) 
(U) (U/mg 
protein) 
(1) Triton X-100 
(7 x 10’ cells) 
(2) Affinity 
chromatography 
28 34320 1125 (1) (100) 
0.04 19680 160333 150 57 
Gershenfeld et al. from a cDNA library by 
hybridization with a mouse HF probe [17] revealed 
identity in all 18 residues. In parallel studies, 
another amino-terminal sequence identical with 
HuHF in 20 out of 22 positions and with HuTSP 
in 17 out of 18 amino acids has been described for 
a CD8+ T cell-derived serine proteinase termed 
431 [24]. As with HuTSP, 431 was found to be a 
disulfide-linked homodimer with a molecular mass 
of 45 kDa under non-reducing conditions. In spite 
of similarities between HuTSP and 431, the latter 
enzyme differs markedly from HuTSP in its 
substrate specificity as well as in its biochemical 
HuTSP 
HuQ31 
HuHF 
MTSP-1 
HuTSP 
HuQ31 
HuHF 
characteristics on a benzamidine Sepharose col- 
umn. Thus it is possible that HuTSP and 431 
belong to a family of related serine proteinases ex- 
pressed by human T effector cells. This assump- 
tion would be in line with the recent demonstration 
by Masson and Tschopp [25] of a family of related 
serine proteinases associated with cytoplasmic 
granules from mouse CD8+ T lymphocytes. 
Amino-terminal sequence analysis revealed that 
these enzymes exhibit variations in residues 5-8 
and identity in residues l-4 and 9-l 6 [24]. In addi- 
tion to HuTSP and 431, a further serine pro- 
teinase that is very similar to the murine 
(Prot. 1 
(Prot.) 
(cDNA) 
Prot./cDNA) 
Ile Ile Gly Gly Asn Glu Val Thr Pro His 
Ile Ile Gly Gly Am Glu Val Thr Pro His 
Ile Ile Gly Gly Asn Glu Val Thr Pro His Ser Arg 
Ile Ile Gly Gly 
(Prot.) Pro Tyr Met Val Leu Leu 
(Prot.) Pro Tyr Met Val Leu Leu Arg Leu Asp Arg Lys Xxx 
(cDNA) Pro Tyr Met Val Leu Leu Ser Leu Asp Arg Lys Thr Ile 
n I I 
MTSPl (Prot./cDNA) 
u u L-l 
Pro Tyr Met Ala Leu Leu Lys Leu Ser Ser Asn Thr Ile 
Fig.2. N-terminal amino acid sequence analysis of HuTSP. A sequence of 18 amino acids of HuTSP was determined and compared 
to the primary structure of T cell tryptase 431, HuHF and MTSP-1. HPLC chromatograms for underlined amino acids in the HuTSP 
sequence showed contaminants/degradation ‘products, but still allowed identification of the respective residues. Regions of identical 
residues are boxed. 
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counterpart MTSP-I [4], BLT-esterase [6], gran- 
zyme A [5] and SE-1 [7] in substrate and inhibitor 
specificities and molecular mass has been isolated 
from cloned human cytolytic T lymphocytes [26]. 
However, since the amino-terminal sequence for 
this enzyme has not been determined the exact rela- 
tionship of this serine proteinase with HuTSP and 
431 is unclear at present. 
The biological function of HuTSP and related 
enzymes remains unknown thus far, but is a matter 
of intensive investigation. However, functional 
studies in the mouse system indicate that MTSP-1 
which, as HuTSP is secreted by T effector cells 
upon ligand binding to the T cell receptor-CD3 
complex [16,27,28], is involved in T cell mediated 
processes uch as cytolysis [ 131, regulation of B cell 
responses [4] and extravasation of activated T cells 
[14,15]. 
The simple technique to purify biochemically 
HuTSP from CD8+ human TLC described here 
and the perspective of generating large amounts of 
the enzyme by DNA technology will allow similar 
functional studies to be initiated with HuTSP in 
the human system. 
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